FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

10 letters match. Newest first.

  1. EpiCare Acquisitions, LLC

    FDA warns EpiCare Acquisitions over unvalidated EpiCare-Zenith lasers and flawed complaint, corrective-action, record, training, and reporting procedures.

    High risk
  2. Jiangsu Shenli Medical Production Co., Ltd.

    FDA: Chinese syringe maker Jiangsu Shenli lacked design controls and device master records, halting US imports.

    High risk
  3. WAVi Co.

    FDA says WAVi sold its unapproved WAVi Desktop brain-assessment device for clinical use and had quality-system failures.

    High risk
  4. BYD Precision Manufacture Co., Ltd

    FDA warned BYD Precision Manufacture over quality-system and reporting failures for surgical masks and an N95 respirator made in Shenzhen, China.

    Medium
  5. Caltag Medsystems Ltd

    FDA warned Caltag Medsystems over quality-system failures in making TransFix/EDTA Vacuum Blood Collection Tubes.

    Medium
  6. Edge Biologicals Inc.

    FDA cited Edge Biologicals Inc. for repeated quality-system violations in its IVD culture media devices, including unvalidated cleaning and sterilization.

    High risk
  7. Sea-Long Medical Systems, LLC

    FDA warns Sea-Long Medical Systems over Treatment Hood quality failures and unapproved uses.

    High risk
  8. Forcemech International LLC

    Forcemech International, a powered wheelchair relabeler in Pearland, Texas, lacked quality system procedures and UDI labeling, FDA says.

    Medium
  9. Global Medical Production Co Ltd

    FDA warns Chinese device maker Global Medical Production that sterile surgical instruments lacked design controls, validation and records, and blocks US imports.

    High risk
  10. Tianjin Bolang Science-Technology Development Co., Ltd.

    FDA found Tianjin Bolang's otoscopes and rigid endoscopes failed device manufacturing rules after a 2021 inspection and is detaining imports.

    High risk